NeuroPace, Inc. (NPCE) vs Tactile Systems Technology, Inc. (TCMD)

NeuroPace, Inc. and Tactile Systems Technology, Inc. are both Medical Devices companies. NeuroPace, Inc. and Tactile Systems Technology, Inc. are of similar size ($518.5M and $479.5M). NeuroPace, Inc. has negative trailing earnings, so its P/E is not meaningful; Tactile Systems Technology, Inc. trades at 20.7×. NeuroPace, Inc. grew revenue faster over the last twelve months: 21.7% against 17.2%. Tactile Systems Technology, Inc. has the higher net margin (7.10% vs −18.6%) and the higher return on invested capital (15.7% vs −44.6%). Across the 18 metrics below, Tactile Systems Technology, Inc. leads on 13 and NeuroPace, Inc. on 5.

Valuation

Metric NPCE TCMD Medical Devices median
P/E n/m 20.66 22.18
P/S 4.66 1.47 2.70
P/B 40.35 2.30 2.46
Price to free cash flow n/m 19.33 22.53
EV/EBITDA n/m 10.84 11.78
EV/Sales 4.75 1.29 2.38
Earnings yield (4.05%) 4.84% (8.22%)
Free cash flow yield (2.42%) 5.17% (7.80%)

Profitability

Metric NPCE TCMD Medical Devices median
Gross margin 78.38% 76.78% 56.01%
Operating margin (13.33%) 10.00% (15.03%)
Net margin (18.58%) 7.10% (20.40%)
Free cash flow margin (11.29%) 7.61% (7.24%)
Return on equity (122.05%) 11.88% (15.32%)
Return on assets (18.82%) 9.00% (19.72%)
Return on invested capital (44.64%) 15.74% (10.33%)

Growth

Metric NPCE TCMD Medical Devices median
Revenue growth (TTM) 21.65% 17.22% 8.80%
EPS growth (last fiscal year) 29.03% 17.14% —
Revenue growth, 5-year CAGR 19.44% 11.98% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NPCE TCMD Medical Devices median
Debt to equity 4.97 0.00 0.07
Current ratio 4.94 4.12 2.50
Net debt to EBITDA 0.15 (2.76) 0.49

Dividend

Metric NPCE TCMD Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric NPCE TCMD Medical Devices median
Market cap 479.51m 518.51m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack